Succinylcholine and malignant hyperthermia.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000328:Adult; D002110:Caffeine / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D003402:Creatine Kinase / Q000097:blood; D000431:Ethanol / Q000633:toxicity; D005334:Fever / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008931:Mitochondria, Muscle / Q000378:metabolism; D009119:Muscle Contraction; D009132:Muscles / Q000187:drug effects; D009135:Muscular Diseases / Q000235:genetics / Q000503:physiopathology*; D009224:Myotonia Congenita; D010101:Oxygen Consumption; D010597:Pharmacogenetics; D010710:Phosphates / Q000378:metabolism; D012519:Sarcoplasmic Reticulum / Q000187:drug effects; D013390:Succinylcholine / Q000494:pharmacology*
D010710:Phosphates; D002110:Caffeine; D000431:Ethanol; D000255:Adenosine Triphosphate; D003402:Creatine Kinase; D013390:Succinylcholine; D002118:Calcium